Retinal OCT and (mfERG) Related to Age, Sex, and the Use of Anti-inflammatory Medications

NACompletedINTERVENTIONAL
Enrollment

218

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2010

Conditions
UveitisIritisIridocyclitisAnterior UveitisMacular Edema
Interventions
DRUG

Diclofenac

"Preservative- free Diclofenac Na 0.1% eye drops (Voltaren Ophta SDU;Novartis Pharms). One drop four times daily in one eys for three days.~The evaluation of macular thickness/function after 3 days use of anti-inflammatory eye drops in healthy subjects is the only sub-study involving an intervention design."

DRUG

Dexamethasone

"Dexamethasone sodium phosphate 0.1% eye drops (Spersadex OmniVision, Novartis Pharma), one drop six times daily for three days in one eye.~Pharms). One drop four times daily in one eys for three days.~The evaluation of macular thickness/function after 3 days use of anti-inflammatory eye drops in healthy subjects is the only sub-study involving an intervention design."

Trial Locations (2)

7006

Department of Ophthalmology, St Olavs University Hospital, Trondheim

7491

Department of Neuroscience, Norwegian University of Science and Technology, Trondheim

All Listed Sponsors
collaborator

St. Olavs Hospital

OTHER

lead

Norwegian University of Science and Technology

OTHER

NCT00476593 - Retinal OCT and (mfERG) Related to Age, Sex, and the Use of Anti-inflammatory Medications | Biotech Hunter | Biotech Hunter